27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
- The FDA has granted 510(k) clearance to Cutera Inc's (NASDAQ:CUTR) AviClear for acne.
- The Company notes that AviClear is the first and only energy-based device to receive this designation to treat mild, moderate, and severe acne.
- AviClear is a laser treatment that offers a safe, prescription-free solution for acne.
- In addition to reducing existing acne, clinical trials show that future breakout episodes are shorter, less intense, and infrequent following the AviClear procedure.
- Further, acne clearance results continue to improve over time, demonstrating the long-term efficacy of the treatment.
- Significantly, no pain mitigation was utilized or required by any clinical study participant.
- Price Action: CUTR shares are up 7.41% at $49.00 during the premarket session on the last check Friday
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!